Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 41,000 shares at $45.11 ($1.8M) on 2021-09-14, disclosed to the SEC on 2021-09-15.
Seasonal sale ($1.8M) by President and CEO — this insider has traded RGNX in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 3,000 | $120K | 6.6% |
| 2 | $40.02 | 3,000 | $120K | 6.6% |
| 3 | $45.11 | 35,000 | $1.6M | 86.8% |
| Total | $44.37 avg | 41,000 | $1.8M | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |